Significant Improvement in Door-to-Needle Times and Clinical Outcomes with “Target: Stroke”

The goal of treating at least 50% of eligible patients in 60 minutes or less was achieved in less than 4 years.

Earlier administration of intravenous thrombolysis for acute ischemic stroke is associated with improved outcomes. Yet, despite nearly two decades of practical experience developing systems of care to rapidly deliver tissue plasminogen activator (TPA), in-hospital delays are still common. To address this challenge, the American Heart Association/American Stroke Association and partner organizations launched the “Target: Stroke” quality improvement initiative in 2010 among hospitals that were participating in the Get With The Guidelines–Stroke registry. The stated goal was to enable participating hospitals to treat at least 50% of eligible patients with TPA within 60 minutes of hospital arrival through the use of a multimodal implementation …

Reviewing Author

Anthony S. Kim, MD, MAS

Disclosures

Grant/Research SupportNIH/National Institute of Neurological Disorders and Stroke; NIH/National Center for Advancing Translational Sciences

Anthony S. Kim, MD, MAS

Disclosures

Grant/Research SupportNIH/National Institute of Neurological Disorders and Stroke; NIH/National Center for Advancing Translational Sciences

Significant Improvement in Door-to-Needle Times and Clinical Outcomes with “Target: Stroke”

Topics

Reviewing Author